... Institute and Harvard Stem Cell Institute(HSCI) have reported successfully reducing symptoms in a Parkinson's disease rat model by using dopamine producing neurons derived from reprogrammed adult skin ...
... retinal pigment epithelial (RPE) cells attached to tiny gelatine bead microcarriers implanted in the brain can improve the symptoms of patients with moderate to advanced Parkinson's disease (PD)...
A well-known growth factor has been shown to increase the growth of new neurons in mice induced to develop Parkinson's disease. The finding highlights a potential new therapy for the condition.
Researchers publishing their studies in CELL TRANSPLANTATION are seeking new ways to treat Parkinson's disease using cell transplantation in animal models. Recent studies are aimed at finding ways to ...
... does the genetics of blood cells have to do with brain cells related to Parkinson's disease? From an unusual collaboration of neurologists and a pharmacologist comes the surprising answer: Genetic ...
... tied to the selective death of dopamine-producing neurons that results in Parkinson's disease.
In this study, researchers found that Hsp104 could partially reverse alpha-synuclein aggregation in ...
A patient who receives a diagnosis of Parkinson's disease might become depressed, and understandably so. But does the depression then exacerbate the progression of Parkinson's?
... using green fluorescent protein and other new approaches in their effort to find cures for Parkinson's disease and other neurodegenerative brain disorders. Morris-Irvin is the first and corresponding ...
Pain appears to be more common in individuals with Parkinson's disease than in those without, suggesting that pain is associated with the condition, according to a report in the September issue of ...
... new grants totaling $21.25 million over a five-year period to study how environmental factors contribute to the cause, prevention and treatment of Parkinson's disease and other related disorders.
... 25(OH)D [a measure of blood vitamin D levels] concentration adds to the risk of developing Parkinson's disease (vs. other neurodegenerative disorders) and to determine whether correction of vitamin D ...
... on the diagnosis and study of the causes of neurocognitive disorders such as autism, schizophrenia and Parkinson's disease," Christ said. "My laboratory recently initiated a grant-funded project that ...
... identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease, according to new research.
... was already thought to be a possible cause of the neuronal cell death associated with Parkinson's disease. The relocation of Parkin to damaged mitochondria, the team showed, sends these defunct ...
... says LeWitt. "Though the start of levodopa can be postponed if the clinical manifestations of Parkinson's disease are mild and tolerable, it may be the only effective option to control discomfort and ...
